Skip to content
Recall Observatory FDA recall evidence

Drug product

Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

D-0492-2023

March 20, 2023

Class II

Product summary

Firm
RemedyRepack Inc.
Event
Event 91980
Status
Terminated
Classification
Class II
Quantity
a) 58 bottles, b) 6 bottles
Official record key
drug-enforcement:D-0492-2023

Official wording

Reason: cGMP Deviations

Code information: Lot #: a) J0665197-120522, Exp. Date 12/31/2023; J0642497-082722, Exp. Date 09/30/2023 J0638552-080922, Exp. Date 08/31/2023. Lot #: b) B1808799-081622, Exp. Date 05/31/2024

Distribution pattern: RemedyRepack distributed product to consignees nationwide within the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations